4′-acetylbenzo-15-crown-5thiosemicarbazone was synthesized with high yield (94%)via the reaction of 4′-acetylbenzo-15-crown-5 and thiosemicarbazide under the microwave irradiation and hydrochloric acid as the cataly...4′-acetylbenzo-15-crown-5thiosemicarbazone was synthesized with high yield (94%)via the reaction of 4′-acetylbenzo-15-crown-5 and thiosemicarbazide under the microwave irradiation and hydrochloric acid as the catalyst.Its structure was determined by single-crystal X-ray diffraction.The crystal belongs to triclinic crystal system,P-1 space group,a=9.5470(19)?,b=13.637(3)?,c=16.029(3)?,α=75.33(3)°,β=83.62(3)°,γ=70.99(3)°,V=1097.8(7)s assembled into supramolecule structure by intermolecular hydrogen bonds.展开更多
目的合成14-N-(3-乙酰基苯)-氨基粉防己碱,并考察其体外抗肿瘤活性。方法本研究以粉防己碱为原料,依次经硝化、还原和Chan-Lam-Evans偶联共计三步反应,合成了一种双苄基异喹啉衍生物,新合成的化合物的结构经核磁共振氢谱(^(1)H-nuclear ...目的合成14-N-(3-乙酰基苯)-氨基粉防己碱,并考察其体外抗肿瘤活性。方法本研究以粉防己碱为原料,依次经硝化、还原和Chan-Lam-Evans偶联共计三步反应,合成了一种双苄基异喹啉衍生物,新合成的化合物的结构经核磁共振氢谱(^(1)H-nuclear magnetic resonance,^(1)H-NMR)、核磁共振碳谱(^(13)C-nuclear magnetic resonance,^(13)C-NMR)和高分辨质谱(high resolution mass spectrometer,HRMS)确证。采用MTT法将所得衍生物14-N-(3-乙酰基苯)粉防己碱对人肝癌细胞HepG2和人正常肝细胞HL7702的体外抑制活性进行了初步评价;通过设计细胞划痕、侵袭实验探究化合物对HepG2细胞迁移和侵袭能力影响。结果MTT实验结果表明,该化合物可以剂量依赖性地抑制HepG2细胞增殖,其IC_(50)值为4.61μmol/L。细胞划痕、侵袭实验表明该化合物明显抑制HepG2细胞迁移和侵袭能力,且呈剂量依赖性,差异具有统计学意义(P<0.005)。结论结果表明,14-N-(3-乙酰基苯)-氨基粉防己碱可作为一种潜在的抗肝癌药物。展开更多
文摘4′-acetylbenzo-15-crown-5thiosemicarbazone was synthesized with high yield (94%)via the reaction of 4′-acetylbenzo-15-crown-5 and thiosemicarbazide under the microwave irradiation and hydrochloric acid as the catalyst.Its structure was determined by single-crystal X-ray diffraction.The crystal belongs to triclinic crystal system,P-1 space group,a=9.5470(19)?,b=13.637(3)?,c=16.029(3)?,α=75.33(3)°,β=83.62(3)°,γ=70.99(3)°,V=1097.8(7)s assembled into supramolecule structure by intermolecular hydrogen bonds.
文摘目的合成14-N-(3-乙酰基苯)-氨基粉防己碱,并考察其体外抗肿瘤活性。方法本研究以粉防己碱为原料,依次经硝化、还原和Chan-Lam-Evans偶联共计三步反应,合成了一种双苄基异喹啉衍生物,新合成的化合物的结构经核磁共振氢谱(^(1)H-nuclear magnetic resonance,^(1)H-NMR)、核磁共振碳谱(^(13)C-nuclear magnetic resonance,^(13)C-NMR)和高分辨质谱(high resolution mass spectrometer,HRMS)确证。采用MTT法将所得衍生物14-N-(3-乙酰基苯)粉防己碱对人肝癌细胞HepG2和人正常肝细胞HL7702的体外抑制活性进行了初步评价;通过设计细胞划痕、侵袭实验探究化合物对HepG2细胞迁移和侵袭能力影响。结果MTT实验结果表明,该化合物可以剂量依赖性地抑制HepG2细胞增殖,其IC_(50)值为4.61μmol/L。细胞划痕、侵袭实验表明该化合物明显抑制HepG2细胞迁移和侵袭能力,且呈剂量依赖性,差异具有统计学意义(P<0.005)。结论结果表明,14-N-(3-乙酰基苯)-氨基粉防己碱可作为一种潜在的抗肝癌药物。